Sutro Biopharma, Inc. · NASDAQ:STRO
BlackRock, Inc. reported a 6.40% stake in Sutro Biopharma, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 30, 2026
BlackRock, Inc. reported a 6.40% stake in Sutro Biopharma, Inc., 1,065,366 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 1,065,366
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.40% | 1,065,366 |
Source
Related
- Sutro Biopharma, Inc.
- BlackRock, Inc.
- Sutro Biopharma, Inc. shareholders
- Form 4 · Gerber Hans-Peter · Sep 22, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Form 4 · Chow Gregory K. · Jun 2, 2026
- Schedule 13G · Srinivas Akkaraju · May 15, 2026